​

Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary

Amneal Pharmaceuticals is owned by 43.29% institutional investors, 46.75% insiders, and 9.96% retail investors. Vanguard group is the largest institutional shareholder, holding 4.79% of AMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.83% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals43.29%46.75%9.96%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group14.84M4.79%$117.55M
Tpg gp a12.33M3.98%$97.64M
Blackrock funding, inc. /de12.13M3.87%$98.14M
Blackrock11.28M3.67%$71.64M
Rubric capital management lp10.72M3.46%$84.92M
Dimensional fund advisors lp4.99M1.61%$39.53M
Nantahala capital management4.37M1.39%$35.33M
Geode capital management3.81M1.23%$30.21M
Neuberger berman group3.76M1.22%$29.79M
State street3.70M1.19%$29.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tucker asset management1.11M1.99%$8.80M
Tpg gp a12.33M1.58%$97.64M
Nantahala capital management4.37M1.38%$35.33M
Blackbarn capital partners lp2.85M1.24%$22.57M
Phocas financial201.89K1.19%$1.60M
Rubric capital management lp10.72M1.09%$84.92M
Jackson creek investment advisors232.59K0.51%$1.88M
Diametric capital, lp96.16K0.42%$777.95K
Numerai gp326.88K0.38%$2.64M
Convergence investment partners159.77K0.33%$1.29M

Top Buyers

HolderShares% AssetsChange
Blackrock11.28M0.00%2.12M
Nantahala capital management4.37M1.38%558.88K
Exoduspoint capital management, lp531.78K0.04%531.78K
Millennium management1.32M0.01%506.97K
Algert global1.04M0.18%480.28K

Top Sellers

HolderShares% AssetsChange
Ubs group1.67M0.00%-20.11M
Fosun---1.72M
Woodline partners lp---1.50M
Hennessy advisors---1.50M
Phocas financial201.89K1.19%-813.30K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp437.33K0.02%437.33K$3.54M
Norges bank86.20K0.00%86.20K$547.37K
American century companies68.13K0.00%68.13K$551.18K
Chartwell investment partners67.93K0.02%67.93K$432.00K
China universal asset management65.70K0.05%65.70K$520.33K

Sold Out

HolderChange
Global retirement partners-1.00
Global financial private client-12.00
Stephens consulting-45.00
Wr wealth planners-59.00
Capital performance advisors llp-163.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202523618.00%134,653,2606.93%432.62%14214.52%5335.90%
Dec 31, 20241997.57%124,789,717-12.50%401.90%12132.97%41-28.07%
Sep 30, 2024183-0.54%141,484,8992.04%452.27%91-14.15%5624.44%
Jun 30, 20241832.81%138,650,46928.21%451.20%1056.06%45-
Mar 31, 202417816.34%108,142,002-0.95%611.23%9916.47%452.27%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.73M1.83%788.50K
Vanguard US Total Market Shares ETF4.36M1.39%-
Vanguard Small Cap Index4.21M1.34%306.85K
iShares Russell 2000 ETF3.57M1.14%-67.83K
Vanguard Small Cap Value Index Inv2.69M0.86%177.03K
Vanguard Institutional Extnd Mkt Idx Tr2.34M0.75%8.88K
Fidelity Small Cap Index1.60M0.51%5.48K
Hennessy Cornerstone Growth Investor1.50M0.48%-171.20K
Columbia Small Cap Value II Inst1.19M0.38%65.17K
Columbia Small Cap Value II1.19M0.38%65.17K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 14, 2025Shah Nikita Executive Vice PresidentSell$666.04K
Aug 15, 2025Konidaris Tasos Executive Vice President & CFOSell$2.07M
Aug 13, 2025Konidaris Tasos Executive Vice President & CFOSell$1.49M
Aug 14, 2025Konidaris Tasos Executive Vice President & CFOSell$1.11M
Aug 12, 2025Shah Nikita Executive Vice PresidentSell$452.00K

Insider Transactions Trends

DateBuySell
2025 Q3-7
2025 Q2-7
2025 Q1-10
2024 Q4-5
2024 Q3-3

AMRX Ownership FAQ

Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 43.29%, followed by 46.75% insiders and 9.96% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Amneal Pharmaceuticals falls below.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Vanguard group (14.84M shares, 4.79%), Tpg gp a (12.33M shares, 3.98%), and Blackrock funding, inc. /de (12.13M shares, 3.87%). Together, they hold 12.64% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tucker asset management is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.99% of its assets in 1.11M Amneal Pharmaceuticals shares, valued at 8.8M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amneal Pharmaceuticals shares, with 1.83% of its total shares outstanding invested in 5.73M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools